|
⚲
|
| Keyboard |
| Oncotelic Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000908259 |
| Sale | 2026-07-10 (0.7 M Offered, 0.7 M Sold) |
| Fund | |
| Phone | 6506357000 |
| Address | 29397 Agoura Road Agoura Hills, CA 91301 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-22 (D) |
| Exemption | 506(b) |
| Duration | More than one year |
| Revenue | No Revenues |
| In the News | |
|---|---|
| Mon, 13 Jul 2026 | Short Interest in Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC) Rises By 320.0% — dailypolitical.com |
| Thu, 11 Jun 2026 | Short Interest in Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC) Declines By 72.6% — dailypolitical.com |
| Tue, 12 May 2026 | Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies — sina.com.hk |
| Thu, 23 Apr 2026 | Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation — montrealgazette.com |
| Tue, 14 Apr 2026 | Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC) Sees Significant Increase in Short Interest — themarketsdaily.com |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Saran Saund | Executive Officer | |
| Seymour Fein | Executive Officer | |
| Shah Amit | Executive Officer | |
| Anthony Maida | Executive Officer | |
| Steven King | Director | |
| Vuong Trieu | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Institutional Venture Management XVII LLC
✚
|
CA | |
|
The Social Capital Partnership LLC
✚
|
CA | |
|
Otherwise Fund Management LLC
✚
|
CA | |
|
Bullpen Management LLC
✚
|
CA | |
|
Type One Management LLC
✚
|
CA | |
|
Hanabi Capital Management LLC
✚
|
CA | |
|
Liquid 2 Ventures LLC
✚
|
CA | |
|
Canvas Management Company LLC
✚
|
CA | |
|
Good Friends LLC
✚
|
CA | |
|
MNS Global Capital Managers LLC
✚
|
CA |